Stocktoria
ALX ONCOLOGY HOLDINGS INC ALXO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-17
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | — | — | $0 | $0 |
| Operating income | -$104.0M | -$142.5M | -$170.3M | -$127.4M | -$83.6M |
| Net income | -$101.7M | -$134.8M | -$160.8M | -$123.5M | -$83.5M |
| Operating cash flow | -$84.1M | -$121.9M | -$130.4M | -$89.2M | -$68.1M |
| Free cash flow | -$84.4M | -$122.4M | -$131.6M | -$90.7M | -$68.8M |
| Total assets | $59.0M | $147.8M | $242.6M | $306.5M | $380.2M |
| Total liabilities | $33.1M | $34.2M | $52.8M | $43.0M | $17.1M |
| Shareholders' equity | $26.0M | $113.6M | $189.7M | $263.5M | $363.0M |
| Ratios | |||||
| Return on assets | -172.2% | -91.3% | -66.3% | -40.3% | -22.0% |
| Return on equity | -391.4% | -118.7% | -84.8% | -46.9% | -23.0% |
| Debt / equity | 0.17× | 0.08× | 0.05× | 0.04× | — |
| Current ratio | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 |
| Revenue growth | — | — | — | — | -100.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 732,599 | $1.5M |
| Point72 Asset Management, L.P. | 41,095 | $82,396 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001810182 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.